
|Articles|June 4, 2007
Latebreakers: OC approved for continuous use
A new birth control pill that is taken daily 365 days a year has received approval. The FDA gave Wyeth the go-ahead for Lybrel, a combination oral contraceptive (OC) that contains 90 mcg levonorgestrel and 20 mcg ethinyl estradiol.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Hormone Replacement Therapy May Lower Dementia Risk in Postmenopausal Women
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
5







































